Vanguard Group’s Fulcrum Therapeutics FULC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$21.6M Sell
3,146,443
-73,935
-2% -$509K ﹤0.01% 2524
2025
Q1
$9.27M Sell
3,220,378
-29,229
-0.9% -$84.2K ﹤0.01% 2889
2024
Q4
$15.3M Sell
3,249,607
-24,985
-0.8% -$117K ﹤0.01% 2727
2024
Q3
$11.7M Buy
3,274,592
+203,449
+7% +$726K ﹤0.01% 2875
2024
Q2
$19M Buy
3,071,143
+532,478
+21% +$3.3M ﹤0.01% 2601
2024
Q1
$24M Buy
2,538,665
+18,681
+0.7% +$176K ﹤0.01% 2513
2023
Q4
$17M Sell
2,519,984
-123,211
-5% -$832K ﹤0.01% 2671
2023
Q3
$11.7M Buy
2,643,195
+17,166
+0.7% +$76.2K ﹤0.01% 2791
2023
Q2
$8.67M Sell
2,626,029
-252,462
-9% -$833K ﹤0.01% 3026
2023
Q1
$8.2M Buy
2,878,491
+757,868
+36% +$2.16M ﹤0.01% 3051
2022
Q4
$15.4M Buy
2,120,623
+164,531
+8% +$1.2M ﹤0.01% 2751
2022
Q3
$15.8M Buy
1,956,092
+426,430
+28% +$3.45M ﹤0.01% 2737
2022
Q2
$7.5M Buy
1,529,662
+25,841
+2% +$127K ﹤0.01% 3147
2022
Q1
$35.6M Buy
1,503,821
+35,162
+2% +$832K ﹤0.01% 2473
2021
Q4
$26M Buy
1,468,659
+215,233
+17% +$3.81M ﹤0.01% 2698
2021
Q3
$35.4M Buy
1,253,426
+346,391
+38% +$9.77M ﹤0.01% 2550
2021
Q2
$9.51M Buy
907,035
+63,840
+8% +$669K ﹤0.01% 3233
2021
Q1
$9.93M Buy
843,195
+181,989
+28% +$2.14M ﹤0.01% 3149
2020
Q4
$7.74M Buy
661,206
+54,654
+9% +$640K ﹤0.01% 3134
2020
Q3
$4.81M Buy
606,552
+181,814
+43% +$1.44M ﹤0.01% 3172
2020
Q2
$7.77M Buy
424,738
+308,821
+266% +$5.65M ﹤0.01% 2889
2020
Q1
$1.38M Buy
115,917
+42,083
+57% +$502K ﹤0.01% 3405
2019
Q4
$1.23M Buy
73,834
+57,837
+362% +$962K ﹤0.01% 3584
2019
Q3
$106K Buy
+15,997
New +$106K ﹤0.01% 4035